Sustained oligoclonal T cell expansion correlates with durable response to anti-PD1 therapy

MLA

Jyoti D. Patel, et al. “Sustained Oligoclonal T Cell Expansion Correlates with Durable Response to Anti-PD1 Therapy.” Journal of Clinical Oncology, vol. 35, May 2017, p. 3061. EBSCOhost, https://doi.org/10.1200/jco.2017.35.15_suppl.3061.

APA

Jyoti D. Patel, Everett E. Vokes, Philip C. Hoffman, Kazuma Kiyotani, Sope Olugbile, Jae-Hyun Park, Livia Szeto, & Yusuke Nakamura. (2017). Sustained oligoclonal T cell expansion correlates with durable response to anti-PD1 therapy. Journal of Clinical Oncology, 35, 3061. https://doi.org/10.1200/jco.2017.35.15_suppl.3061

Chicago

Jyoti D. Patel, Everett E. Vokes, Philip C. Hoffman, Kazuma Kiyotani, Sope Olugbile, Jae-Hyun Park, Livia Szeto, and Yusuke Nakamura. 2017. “Sustained Oligoclonal T Cell Expansion Correlates with Durable Response to Anti-PD1 Therapy.” Journal of Clinical Oncology 35 (May): 3061. doi:10.1200/jco.2017.35.15_suppl.3061.